Blume Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $132K | Hold |
325
| – | – | 0.03% | 134 |
|
|
2025
Q1 | $162K | Hold |
325
| – | – | 0.04% | 121 |
|
|
2024
Q4 | $169K | Hold |
325
| – | – | 0.04% | 119 |
|
|
2024
Q3 | $201K | Hold |
325
| – | – | 0.05% | 112 |
|
|
2024
Q2 | $180K | Sell |
325
-50
| -13% | -$27.7K | 0.04% | 108 |
|
|
2024
Q1 | $218K | Sell |
375
-25
| -6% | -$14.5K | 0.05% | 93 |
|
|
2023
Q4 | $212K | Hold |
400
| – | – | 0.06% | 87 |
|
|
2023
Q3 | $202K | Hold |
400
| – | – | 0.06% | 90 |
|
|
2023
Q2 | $209K | Hold |
400
| – | – | 0.06% | 87 |
|
|
2023
Q1 | $231K | Sell |
400
-30
| -7% | -$17.3K | 0.07% | 80 |
|
|
2022
Q4 | $237K | Hold |
430
| – | – | 0.08% | 85 |
|
|
2022
Q3 | $218K | Hold |
430
| – | – | 0.08% | 75 |
|
|
2022
Q2 | $234K | Hold |
430
| – | – | 0.09% | 73 |
|
|
2022
Q1 | $254K | Hold |
430
| – | – | 0.08% | 71 |
|
|
2021
Q4 | $287K | Hold |
430
| – | – | 0.09% | 75 |
|
|
2021
Q3 | $246K | Hold |
430
| – | – | 0.09% | 76 |
|
|
2021
Q2 | $217K | Hold |
430
| – | – | 0.08% | 79 |
|
|
2021
Q1 | $196K | Buy |
+430
| New | +$196K | 0.08% | 78 |
|